Clinical Trials in the Category "Urogenital Neoplasms"

Drug Intervention Trials that are Recruiting

Study Title	Principal Investigator	Disease Category

Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer	Dr. Sandy Srinivas	Prostatic Neoplasms

Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer	Dr. Sandy Srinivas	Urogenital Cancer

Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer	Dr. Sandy Srinivas	Kidney Diseases Carcinoma, Renal Cell

Temsirolimus and Sorafenib as Second-Line Therapy in Patients With Advanced RCC Who Failed First-Line Sunitinib	Dr. Sandy Srinivas	Kidney Neoplasms Carcinoma, Renal Cell

Study of XL880 in Subjects With Papillary Renal Cell Carcinoma	Dr. Sandy Srinivas	Carcinoma, Papillary Kidney Neoplasms Carcinoma, Renal Cell

Vincristine and Dactinomycin With or Without Doxorubicin and Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor	Dr. Neyssa Marina	Wilms Tumor

Ixabepilone in Treating Young Patients With Refractory Solid Tumors	Dr. Neyssa Marina	Sarcoma Wilms Tumor Neuroblastoma

Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer	Dr. Sandy Srinivas	Prostatic Neoplasms

Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer	Amreen Husain	Endometrial Neoplasms

Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer	Amreen Husain	Uterine Neoplasms Uterine Cervical Neoplasms Adenocarcinoma Carcinoma, Squamous Cell

Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery	Dr. Sandy Srinivas	Kidney Neoplasms Carcinoma, Renal Cell

Treatment of Refractory Metastatic Renal Cell Carcinoma with Bevacizumab and RADOO1	Dr. Sandy Srinivas	Kidney Neoplasms

Phase III Study of Aflibercept vs Placebo for Metastatic Androgen-Independent Prostate Cancer	Dr. Sandy Srinivas	Prostatic Neoplasms Neoplasm Metastasis

Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites	Jonathan S. Berek MD, MMS	Ovarian Cancer Ascites

Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors	Dr. Neyssa Marina	Ovarian Cancer Neoplasms, Germ Cell and Embryonal

A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma (OCEANS)	Jonathan S. Berek MD, MMS	Ovarian Cancer

AZD6244 in Treating Woman With Recurrent Low-Grade Ovarian Cancer	Amreen Husain	Ovarian Cancer

Randomized Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer	Dr. Sandy Srinivas	Bladder Cancer

A Phase 1 Study of an Oral VEGFR Inhibitor (AV-951) in Combination With Torisel in Renal Cell Cancer	Dr. Sandy Srinivas	Carcinoma, Renal Cell

Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI	Dr Andrew Quon	Kidney Neoplasms Carcinoma, Renal Cell

Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer	Amreen Husain	Ovarian Cancer Fallopian Tube Neoplasms Peritoneal Neoplasms

Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries	Amreen Husain	Ovarian Cancer Osteoporosis Breast Cancer

AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer	Dr. Sandy Srinivas	Prostatic Neoplasms

Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer	Jonathan S. Berek MD, MMS	Ovarian Cancer

Pre-Surgical Detection of Clear Cell Renal Cell Carcinoma Using Radiolabeled G250-Antibody	Benjamin I. Chung	Kidney Neoplasms Carcinoma, Renal Cell

Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer	Amreen Husain	Endometrial Neoplasms

Device Intervention Trials that are Recruiting

Study Title	Principal Investigator	Disease Category

Fiber-Optic Confocal Microscopy of the Urinary Tract Histopathology	Joseph C. Liao	Bladder Cancer

Other Trials that are Recruiting

Study Title	Principal Investigator	Disease Category

Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors	Kate R Lorig	Breast Cancer Prostatic Neoplasms Colorectal Neoplasms Anal, Colon, and Rectal Cancers Blood Cancer

Collecting Tumor Samples From Patients With Gynecological Tumors	Amreen Husain	Ovarian Cancer

Microarray Analysis of Gene Expression in Prostate Tissues	James D Brooks	Prostatic Neoplasms

Quality of Life Following Radical Prostatectomy	Joseph C. Presti Jr.	Prostatic Neoplasms

18 F-fluoride PET/CT versus 99Tc-MDP Scanning for Detecting Bone Metastases	Sanjiv Sam Gambhir M.D., Ph.D.	Breast Cancer Prostatic Neoplasms Bone Cancer Lung Cancer

Prostate Active Surveillance Study (PASS)	James D Brooks	Prostatic Neoplasms

Trials not Recruiting

Study Title	Principal Investigator	Disease Category

Clinical Trial for Ovarian Cancer (OvaRex®) *(Terminated)*	Nelson N Teng	Ovarian Cancer

Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer *(Completed)*	Dr. Sandy Srinivas	Urologic Neoplasms

Safety and Efficacy Study of the Trifunctional Antibody Catumaxomab to Treat Ovarian Cancer in Women After a Complete Response to Chemotherapy *(Completed)*	Jonathan S. Berek MD, MMS	Ovarian Cancer

A Study Evaluating the Efficacy and Safety of Sutinib With or Without Bevacizumab in First-Line Patients With Metastatic Renal Cell Cancer (SABRE-R) *(No longer recruiting)*	Dr. Sandy Srinivas	Kidney Neoplasms Carcinoma, Renal Cell

"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk *(No longer recruiting)*	Harcharan Gill	Urogenital Cancer Prostatic Neoplasms Genital Diseases, Male

Phase 2 Trial of Enzastaurin in Prostate Cancer in Patients Who Have Had Hormonal and Chemotherapy *(No longer recruiting)*	Dr. Sandy Srinivas	Prostatic Neoplasms

First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy *(Completed)*	Dr. Sandy Srinivas	Carcinoma, Transitional Cell Bladder Cancer

Hypofractionated Radiotherapy for Localized Prostate Cancer (with CyberKnife or with IMRT) *(Completed)*	Christopher R. King	Prostatic Neoplasms

Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer *(No longer recruiting)*	Amreen Husain	Uterine Cervical Neoplasms

Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients (MIMOSA) *(No longer recruiting)*	Jonathan S. Berek MD, MMS	Ovarian Cancer

Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer *(No longer recruiting)*	Amreen Husain	Ovarian Cancer

A Pilot Study Evaluating Oral Triamcinalone in Patients with Androgen Independent Prostate Cancer *(Completed)*	Dr. Sandy Srinivas	Prostatic Neoplasms

A Phase II Trial of Calcitriol and Naproxen in Patients with Recurrent Prostate Cancer *(Suspended)*	Dr. Sandy Srinivas	Prostatic Neoplasms

Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance *(No longer recruiting)*	Joseph C. Presti Jr.	Prostatic Neoplasms

A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma *(Completed)*	Dr. Sandy Srinivas	Kidney Neoplasms

Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer *(Completed)*	Dr. Sandy Srinivas	Prostatic Neoplasms

Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy *(Completed)*	Joseph C. Presti Jr.	Bladder Cancer

Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer *(No longer recruiting)*	Amreen Husain	Ovarian Cancer

A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-Resistant Prostate Cancer (IPI-504-04) *(No longer recruiting)*	Dr. Sandy Srinivas	Prostatic Neoplasms

A Phase II Study of AZD4877 (a Novel Anti-Mitotic Agent) in Advanced Bladder Cancer *(No longer recruiting)*	Dr. Sandy Srinivas	Ureteral Neoplasms Pelvic Neoplasms Kidney Neoplasms Urethral Neoplasms Bladder Cancer

Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium *(No longer recruiting)*	Dr. Sandy Srinivas	Ureteral Neoplasms Kidney Neoplasms Urethral Neoplasms Bladder Cancer

Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer *(No longer recruiting)*	Amreen Husain	Uterine Cervical Neoplasms

MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer *(Completed)*	Dr. Sandy Srinivas	Prostatic Neoplasms

Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma *(No longer recruiting)*	Dr. Sandy Srinivas	Kidney Neoplasms

The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials. Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials.

Clinical Trials in the Category "Urogenital Neoplasms"

Drug Intervention Trials that are Recruiting

Device Intervention Trials that are Recruiting

Other Trials that are Recruiting

Trials not Recruiting

Navigation for This Section: Clinical Trials

Site Navigation:

Stanford Medicine Resources:

Footer Links:

Clinical Trials in the Category "Urogenital Neoplasms"

Drug Intervention Trials that are Recruiting

Device Intervention Trials that are Recruiting

Other Trials that are Recruiting

Trials not Recruiting

You are Here:

Navigation for This Section: Clinical Trials

Site Navigation:

Stanford Medicine Resources:

Footer Links: